The importance of treating pediatric AIDS in the elimination agenda

Scott Kellerman and colleagues argue that the scope of the current HIV elimination agenda must be broadened in order to ensure access to care and treatment for all children living with HIV.

In 2011, despite the global initiative to eliminate mother-to-child transmission of HIV, 330,000 new pediatric infections were added worldwide to the existing pool of 3.4 million children living with the virus. Children are more vulnerable to HIV infection and have higher morbidity and mortality. Without treatment, half of those children infected will die before the age of 2 years, yet only one third of those eligible for treatment are currently receiving antiretroviral therapy.

The paper argues that current initiatives focus on interventions within the traditional prevention cascade which involve prevention of mother-to-child transmission. This focus is welcome but it is not enough. The scope of the elimination agenda must be broadened in order to ensure access to care and treatment for all children living with HIV. This expanded agenda must address challenges around reducing and ensuring access to appropriate HIV testing, care, and treatment for all affected children.

More information: Kellerman SE, Sugandhi N (2013) Pediatric AIDS in the Elimination Agenda. PLoS Med 10(8):e1001503. DOI: 10.1371/journal.pmed.1001503

add to favorites email to friend print save as pdf

Related Stories

Study details age disparities in HIV continuum of care

Jun 17, 2013

Age disparities exist in the continuum of care for patients with the human immunodeficiency virus (HIV) with people younger than 45 years less likely to be aware of their infection or to have a suppressed viral load, according ...

HIV testing for children must be improved

Jul 20, 2010

National HIV programs should recognize that HIV testing and counseling systems designed for adults do not meet the needs of children. Therefore, according to Scott Kellerman from Management Sciences for Health, Virginia, ...

HIV answers raise new ethical questions

Jul 31, 2013

The Food and Drug Administration's approval last year of the drug Truvada for prevention of HIV infection was a milestone in the fight against HIV/AIDS, but experts are cautioning that it is only the beginning of new ethical ...

Recommended for you

HIV+ women respond well to HPV vaccine

20 hours ago

HIV-positive women respond well to a vaccine against the human papillomavirus (HPV), even when their immune system is struggling, according to newly published results of an international clinical trial. The study's findings ...

HIV battle must focus on hard-hit streets, paper argues

Apr 10, 2014

In U.S. cities, it's not just what you do, but also your address that can determine whether you will get HIV and whether you will survive. A new paper in the American Journal of Public Health illustrates the ef ...

User comments